Page breadcrumb nav

VAERS Report 2156716

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: fl9994


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-02-12
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

primary immunisation: unknown manufacturer; booster: comirnaty (4th dose).; primary immunisation: unknown manufacturer; booster: comirnaty (4th dose).; lymph node pain; painful; not feeling well; cold; hot sweating; cannot eat; can't sleep; this is a spontaneous report received from a contactable reporter (consumer or other non-hcp) from the regulatory agency. regulatory number: gb-mhra-webcovid-202202141823259420-itdfu. other case identifier(s): gb-mhra-adr 26603070. a female patient received bnt162b2 (comirnaty), administration date 12feb2022 (lot number: fl9994) as dose 4 (booster), single for covid-19 immunisation. relevant medical history included: "immunodeficiency" (unspecified if ongoing), notes: taking treatments or medicines and has an illness or condition known to lower the immune response.; "steroid therapy" (unspecified if ongoing), notes: taking regular steroid treatment (e.g. orally or rectally). the patient's concomitant medications were not reported. vaccination history included: covid-19 vaccine (dose 3; manufacturer unknown), for covid-19 immunisation; covid-19 vaccine (dose 2; manufacturer unknown), for covid-19 immunisation; covid-19 vaccine (dose 1; manufacturer unknown), for covid-19 immunisation. the following information was reported: off label use (medically significant), immunisation (medically significant) all with onset 12feb2022, outcome "unknown" and all described as "primary immunisation: unknown manufacturer; booster: comirnaty (4th dose)."; lymph node pain (medically significant) with onset 12feb2022, outcome "recovering", described as "lymph node pain"; pain (medically significant) with onset feb2022, outcome "unknown", described as "painful"; malaise (medically significant) with onset feb2022, outcome "unknown", described as "not feeling well"; nasopharyngitis (medically significant) with onset feb2022, outcome "unknown", described as "cold"; hyperhidrosis (medically significant) with onset feb2022, outcome "unknown", described as "hot sweating"; decreased appetite (medically significant) with onset feb2022, outcome "unknown", described as "cannot eat"; insomnia (medically significant) with onset feb2022, outcome "unknown", described as "can't sleep". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: (12feb2022) no - negative covid-19 test. patient had not tested positive for covid-19 since having the vaccine. patient was not enrolled in clinical trial. no follow-up attempts are possible. no further information is expected

Données de laboratoire
test date: 20220212; test name: covid-19 virus test; result unstructured data: test result:no - negative covid-19 test
Liste des symptômes
hyperhidrosis malaise decreased appetite pain insomnia lymph node pain nasopharyngitis sars-cov-2 test immunisation off label use
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na